The iwCLL Biennial Meeting is designed to advance the field of chronic lymphocytic Leukemia (CLL) and related lymphoproliferative disorders. It is attended every two years by CLL practitioners and researchers from all over the globe, for a thought-provoking four days of lectures, debate, discussion and networking, led by international experts.
This year the panel of prestigious international experts includes:
Tadeusz Robak MD, Ph.D
Professor of Haematology at the Medical University of Lodz, Poland, current president of the Polish Society of Haematology and a member of European Haematology Association and American Society for Haematology.
Professor John Seymour MB BS FRACP PhD AM
Director of Clinical Haematology of The Royal Melbourne Hospital, a clinical haematologist and Associate Director of Clinical Research at the Peter MacCallum Centre. The principal investigator on more than 85 clinical trials and chief investigator on competitive grants awarded over AUD$18 million funding in the last 10 years. In 2015, he was awarded Membership of the Order of Australia and elected to the Australian Academy of Health and Medical Sciences for his contributions to the field.
Tamar Tadmor, Associate Professor, Head of Hematology Unit
Bnai Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine
Haifa, Israel
Martina Seiffert PhD
Group Leader, Division of Molecular Genetics German Cancer Research Center
Heidelberg, Germany. She is interested in immune modulatory mechansism in the tumor microenvironment, with a focus on chronic lymphocytic leukemia. Martina Seiffert is a member of national and international research associations, heads various third-party funded projects and coordinates international research consortia.
Prof. Marek Mráz, Ph.D.
Trained in both clinical medicine and molecular biology and conducted postdoctoral research in the United States at the University of California, San Diego, and Mayo Clinic. He received a grant from the European Hematology Association (2015), prestigious ERC Starting Grant from the European Research Council (2019), and in 2024 the most prestigious national grant (GACR EXPRO). He collaborates closely with hematologists at University Hospital Brno and with many international teams.
Dr Elisa ten Hacken, PhD
Assistant Professor of Cancer Biology at Weill Cornell Medicine since March 2023. Joined Dr. Catherine Wu’s lab at Dana Farber Cancer Institute in Boston in July 2016 for a second postdoctoral fellowship, appointed as Instructor in Medicine at Harvard Medical School in 2019. With a longstanding interest in chronic lymphocytic leukemia and a current focus on functional genomics of Richter’s syndrome. Her work is currently supported by the Leukemia and Lymphoma Society, the American Society of Hematology, NIH/NCI, amongst others.
As in past years, the XXI iwCLL in Kraków will be evidence-based, well balanced, and provide useful insights in an effective format that is relevant to the changing landscape of CLL.
If you are looking to connect, network, and hear the expert haematologists and leaders in the field of CLL share the latest developments, please join us in Kraków.The full program can be found on the XXI iwCLL Meeting website here.